Form IV of carbamazepine
dc.contributor.author | Lang, Meidong | en_US |
dc.contributor.author | Kampf, Jeffrey W. | en_US |
dc.contributor.author | Matzger, Adam J. | en_US |
dc.date.accessioned | 2006-04-19T13:37:32Z | |
dc.date.available | 2006-04-19T13:37:32Z | |
dc.date.issued | 2002-04 | en_US |
dc.identifier.citation | Lang, Meidong; Kampf, Jeff W.; Matzger, Adam J. (2002)."Form IV of carbamazepine." Journal of Pharmaceutical Sciences 91(4): 1186-1190. <http://hdl.handle.net/2027.42/34507> | en_US |
dc.identifier.issn | 0022-3549 | en_US |
dc.identifier.issn | 1520-6017 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/34507 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11948557&dopt=citation | en_US |
dc.description.abstract | Carbamazepine has been found to crystallize as a new polymorph that is stable at room temperature. We report the crystal structure of this C -centered monoclinic form (space group C 2/ c , cell parameters: a = 26.609, b = 6.9269, c = 13.957, Β = 109.702), which consists of hydrogen bonded dimers with an anti -disposition. This represents the third modification of carbamazepine that has been crystallographically characterized, and the fourth for which cell parameters have been determined. Thus, it is designated as form IV of carbamazepine. Differences between the packing of the various polymorphs are discussed. © 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 91:1186–1190, 2002 | en_US |
dc.format.extent | 120816 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Chemistry | en_US |
dc.subject.other | Food Science, Agricultural, Medicinal and Pharmaceutical Chemistry | en_US |
dc.title | Form IV of carbamazepine | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Chemistry and Department of Macromolecular Science and Engineering, The University of Michigan, Ann Arbor, Michigan 48109-1055 | en_US |
dc.contributor.affiliationum | Department of Chemistry and Department of Macromolecular Science and Engineering, The University of Michigan, Ann Arbor, Michigan 48109-1055 | en_US |
dc.contributor.affiliationum | Department of Chemistry and Department of Macromolecular Science and Engineering, The University of Michigan, Ann Arbor, Michigan 48109-1055 ; Department of Chemistry and Department of Macromolecular Science and Engineering, The University of Michigan, Ann Arbor, Michigan 48109-1055. Telephone: 734-615-6627; Fax: 734-615-8553 | en_US |
dc.identifier.pmid | 11948557 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/34507/1/10093_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1002/jps.10093 | en_US |
dc.identifier.source | Journal of Pharmaceutical Sciences | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.